General Information


DRAVP ID  DRAVPe00130

Peptide Name   vif 155-166

Sequence  KPKQIKPPLPSV

Sequence Length  12

UniProt ID  No entry found

Source  Synthetic construct(derived from the proline-enriched C terminus of Vif)



Activity Information


Target Organism  HIV

Assay  ELISA

Activity 

  • [Ref.12480936]HIV-1:inhibition of Vif-Vif bingding(IC50=17.39 μM);
  • The peptide is able to effectively inhibit HIV-1 replication At the concentration of 50 μM.

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref.12480936]No significant cytotoxicity on H9 cells up to 50 μM.

Binding Target  Vif proteins

Mechanism  Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00130

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C63H110N16O15

Absent amino acids  ACDEFGHMNRTWY

Common amino acids  P

Mass  1331.66

Pl  10.3

Basic residues  3

Acidic residues  0

Hydrophobic residues  3

Net charge  3

Boman Index  -1171

Hydrophobicity  -82.5

Aliphatic Index  89.17

Half Life 

  •     Mammalian:1.3 hour
  •     Yeast:3 min
  •     E.coli:2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1



Literature Information


Literature 1

Title   Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.

Pubmed ID   12480936

Reference   J Biol Chem. 2003 Feb 21;278(8):6596-602.

Author   Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H.

DOI   10.1074/jbc.M210164200